Clinical Trials

NCT IdNCT04834128
TitleTCB008 in Patients With COVID-19
ConditionCovid19
StudyTypeInterventional
OrganizationTC Biopharm
Sponsor/CollaboratorsTC Biopharm
StatusNot yet recruiting
GenderAll
AgeGroupAdult
Older Adult
Location (with distance)
DescriptionA Phase II safety and tolerability study of expanded gamma delta T cell lymphocytes (TCB008) in patients diagnosed with COVID-19.